PhoenixBio Co., Ltd. (JP:6190)
:6190
Total Valuation
PhoenixBio Co., Ltd. has a market cap or net worth of ¥1.88B. The enterprise value is ¥1.33B.
Market Cap¥1.88B
Enterprise Value¥1.33B
Share Statistics
PhoenixBio Co., Ltd. has 4,076,933 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,076,933
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PhoenixBio Co., Ltd.’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -6.91%.
Return on Equity (ROE)-0.33
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-6.91%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee22.02M
Profits Per Employee-6.37M
Employee Count70
Asset Turnover0.67
Inventory Turnover1.30
Valuation Ratios
The current PE Ratio of PhoenixBio Co., Ltd. is 6.1. PhoenixBio Co., Ltd.’s PEG ratio is 0.00200.
PE Ratio6.1
PS Ratio0.97
PB Ratio1.09
Price to Fair Value1.09
Price to FCF-15.84
Price to Operating Cash Flow0.00
PEG Ratio0.00200
Income Statement
In the last 12 months, PhoenixBio Co., Ltd. had revenue of 1.54B and earned -445.65M in profits. Earnings per share was -110.18.
Revenue1.54B
Gross Profit1.11B
Operating Income-135.17M
Pretax Income-429.56M
Net Income-445.65M
EBITDA-396.12M
Earnings Per Share (EPS)-110.18
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
PhoenixBio Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change76.92%
50-Day Moving Average466.22
200-Day Moving Average453.97
Relative Strength Index (RSI)49.75
Average Volume (3m)360.67K
Important Dates
PhoenixBio Co., Ltd. upcoming earnings date is May 15, 2026, TBA (Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 15, 2026
Ex-Dividend Date―
Financial Position
PhoenixBio Co., Ltd. as a current ratio of 3.03, with Debt / Equity ratio of 31.14%
Current Ratio3.03
Quick Ratio2.44
Debt to Market Cap0.27
Net Debt to EBITDA1.47
Interest Coverage Ratio-25.77
Taxes
In the past 12 months, PhoenixBio Co., Ltd. has paid 16.09M in taxes.
Income Tax16.09M
Effective Tax Rate-0.04
Enterprise Valuation
PhoenixBio Co., Ltd. EV to EBITDA ratio is -2.29, with an EV/FCF ratio of -9.64.
EV to Sales0.59
EV to EBITDA-2.29
EV to Free Cash Flow-9.64
EV to Operating Cash Flow-12.44
Balance Sheet
PhoenixBio Co., Ltd. has ¥1.04B in cash and marketable securities with ¥503.59M in debt, giving a net cash position of ¥532.32M billion.
Cash & Marketable Securities¥1.04B
Total Debt¥503.59M
Net Cash¥532.32M
Net Cash Per Share¥130.57
Tangible Book Value Per Share¥333.07
Margins
Gross margin is 78.44%, with operating margin of -8.77%, and net profit margin of -28.91%.
Gross Margin78.44%
Operating Margin-8.77%
Pretax Margin-27.87%
Net Profit Margin-28.91%
EBITDA Margin-25.70%
EBIT Margin-27.53%
Analyst Forecast
The average price target for PhoenixBio Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-6.92%
EPS Growth Forecast-144.96%